Anindya Bijoy Das | ML in Healthcare | Innovative Research Award

Innovative Research Award

Anindya Bijoy Das
The University of Akron
Anindya Bijoy Das
Affiliation The University of Akron
Country United States
Scopus ID 57701018300
Documents 34
Citations 392
h-index 10
Subject Area ML in Healthcare
Event International AI Data Scientists Award
ORCID 0000-0002-3615-7400

Anindya Bijoy Das is a researcher affiliated with The University of Akron, United States. His scholarly work contributes to the advancement of machine learning applications in healthcare, with emphasis on data-driven methods that support clinical decision-making, predictive analytics, and biomedical research. Based on available publication and citation metrics, his research demonstrates sustained academic engagement and measurable scientific impact within interdisciplinary domains.[1]

Abstract

This article presents an academic overview of Anindya Bijoy Das and highlights contributions in machine learning for healthcare. The profile summarizes scholarly output, citation performance, research impact, and relevance to innovation-oriented academic recognition programs.[1]

Keywords

Machine Learning, Healthcare Analytics, Artificial Intelligence, Biomedical Data Science, Predictive Modeling, Clinical Informatics.

Introduction

The integration of artificial intelligence into healthcare has transformed modern research and clinical practice. Researchers such as Anindya Bijoy Das contribute to this evolving field by developing analytical frameworks and intelligent methodologies that support improved healthcare outcomes and evidence-based decision-making.[2]

Research Profile

The research profile of Anindya Bijoy Das reflects interdisciplinary expertise spanning machine learning, healthcare data analysis, and computational methodologies. With 34 indexed documents and 392 citations, the profile indicates active participation in internationally recognized scholarly communication channels.[1]

Research Contributions

Key contributions involve the application of advanced machine learning techniques to healthcare datasets, enabling improved prediction, classification, and data interpretation. Such work supports the broader objective of translating computational innovation into practical healthcare solutions.[2]

Publications

  • Research publications in machine learning and healthcare analytics.
  • Studies addressing predictive healthcare models and intelligent systems.
  • Collaborative research contributing to data-driven medical innovation.

Research Impact

Citation metrics and publication records indicate meaningful academic influence. An h-index of 10 reflects consistent citation activity across multiple publications, demonstrating visibility within the scientific community and engagement with contemporary healthcare research challenges.[1]

Award Suitability

The researcher’s publication performance, interdisciplinary contributions, and focus on machine learning in healthcare align with the objectives of the International AI Data Scientists Award. The profile reflects innovation, scholarly productivity, and measurable research impact suitable for academic recognition.[3]

Conclusion

Anindya Bijoy Das has established a research profile characterized by consistent scholarly output and contributions to healthcare-focused artificial intelligence. The available evidence supports recognition of his work within academic and innovation-oriented award frameworks.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Anindya Bijoy Das, Author ID 57701018300. Scopus. https://www.scopus.com/pages/authors/57701018300
  2. Artificial Intelligence in Healthcare Literature.
    https://doi.org/10.1016/j.artmed.2020.101944
  3. International AI Data Scientists Award.
    https://aidatascientists.com/

Emelina Stambolliu | AI in Healthcare | Excellence in Research Award

Dr. Emelina Stambolliu | AI in Healthcare | Excellence in Research Award

Supervising physician | Hippokration General Hopsital of Athens,Greece | Greece

Dr. Emelina Stambolliu is a clinician-researcher at Hippokration General Hospital of Athens whose work focuses on hypertension, kidney disease, and cardiovascular risk, with growing integration of AI-driven analysis in healthcare. Her research emphasizes advanced blood pressure monitoring (office, home, ambulatory), early detection of target-organ damage, and cardiorenal interactions across pediatric and adult populations. She has contributed extensively to evidence-based clinical decision support, systematic reviews, and validation of medical monitoring devices, supporting precision medicine and data-informed patient care


View Orcid Profile

Featured Publications

Dr. Farnaz Farid | Healthcare industry | Best Researcher Award

Dr. Farnaz Farid | Healthcare industry | Best Researcher Award

Multidisciplinary Researcher, Western Sydney University, Australia

Dr. Farnaz Farid is a distinguished and multidisciplinary researcher whose academic journey and professional experience span industry and academia, combining expertise in artificial intelligence, cybersecurity, human-centered systems, and applied computing. She holds a Doctor of Philosophy (PhD) degree from Western Sydney University, where her doctoral research focused on computational modeling, AI-driven predictive systems, and network quality of service frameworks; she also earned earlier degrees in engineering and computing from reputable institutions that shaped her foundation in IT, networks, and systems. Over the years, Dr. Farnaz Farid has served in both industry and academic roles: prior to joining academia, she worked at IBM as an IT Specialist, Application Developer, and Project Manager, contributing to enterprise integration, software development, and digital innovation; subsequently, she entered academia as an Associate Lecturer at the University of Sydney and then moved to Western Sydney University, where she is now a Senior Lecturer and Academic Program Advisor, co-leading global initiatives such as “Realising Digital Futures.” Her professional experience includes overseeing cross-disciplinary projects in AI, cybersecurity, IoT, and smart systems, mentoring postgraduate researchers, guiding curriculum development, and fostering partnerships with industry and community stakeholders. Her research interests encompass explainable AI, human-centred security, AI for healthcare, cyber‐physical systems, distributed networks, federated learning, and digital inclusion. Dr. Farid has received a number of awards and honors, such as the Google exploreCSR grant over multiple years to lead community‐based AI projects, the DVC Education Excellence in Teaching (Partnerships) award at her university, and the Teaching and Learning for Public Good Award in Social Sciences, all of which attest to her excellence in teaching, public engagement, and socially impactful research. Through her editorial service (for journals such as Symmetry and Sustainability), membership in the Asian Council of Science Editors (ACSE), and leadership of cross‐disciplinary grants, she has also contributed to the scientific community.

Profile: GOOGLE SCHOLAR  | SCOPUS | ORCID

Featured Publications

  • Farid, F. (2025). An explainable predictive model for the detection of mental health conditions in the workplace. (citation count: 13)

  • Farid, F. (2025). A threat analysis framework for cyberattacks in smart cities: ransomware in focus. (citation count: 24)

  • Dong, H., & Farid, F. (2024). A deep learning based patient care application for skin cancer detection.

  • Farid, F., & colleagues. (2024). AI technologies in reducing hospital readmission for chronic diseases: a recommended framework.

  • Lai, T., & Farid, F. (2024). Ensemble learning for IoT cybersecurity via Bayesian hyperparameters sensitivity analysis.

Neeraj Thakur | AI in Healthcare | Best Researcher Award

Dr. Neeraj Thakur | AI in Healthcare | Best Researcher Award

Postdoctoral Fellow at University of Oklahoma Health Sciences, United States

Dr. Neeraj S. Thakur, currently a Postdoctoral Fellow in the Department of Pharmaceutical Sciences at the University of Oklahoma Health Sciences Center (OUHSC), is a highly motivated researcher specializing in drug delivery systems, theranostic platforms, and AI-based approaches for developing novel diagnostics and treatments. With over a decade of international research experience spanning the USA, Europe, and Asia, Dr. Thakur has led multiple projects related to nanomaterial design, formulation development, and the synthesis of advanced drug delivery systems for treating diseases like cancer and infections. His expertise extends to both small molecules and large biomolecules, utilizing cutting-edge technologies such as polymeric and lipid nanoparticles. He has an extensive publication record with 29 papers, five patents, six book chapters, and significant contributions to the field.

Profile

Scopus

Education

Dr. Thakur earned his Ph.D. in Pharmaceutical Technology (Biotechnology) from the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India, where his research focused on the development of nanoparticle-based fluorescent probes for biomedical applications. He also holds an M.Tech in Pharmaceutical Technology (Biotechnology) from NIPER, Mohali, where he was the class topper, and a B.Pharm degree from Shri G.S. Institute of Technology and Science, Indore. Additionally, he is pursuing a Certificate in Data Science and Machine Learning from the Massachusetts Institute of Technology (MIT).

Experience

Dr. Thakur has held significant roles in various research institutions. As a Postdoctoral Fellow at OUHSC, he established research laboratories and led projects on nanomaterial development for drug delivery systems targeting multiple applications, including inner ear and ocular delivery. Prior to this, he worked at the University of Geneva, Switzerland, where he developed hybrid micelle formulations for transdermal delivery and designed iontophoretic devices. He also contributed to the Center of Innovative and Applied Bioprocessing (CIAB), India, where he led the development of topical drug delivery systems and was involved in several patent filings. These experiences have honed his skills in formulation and analytical development, laboratory management, and industrial collaboration.

Research Interests

Dr. Thakur’s research interests focus on the development of advanced drug delivery systems, particularly using nanomaterials such as polymeric and lipid nanoparticles. His work aims to improve the therapeutic efficacy of drugs by enhancing their delivery to specific sites in the body, such as the inner ear, ocular tissues, and tumors. He is also dedicated to the integration of AI-based approaches for optimizing drug delivery design, ensuring more precise treatments for conditions like cancer and ototoxicity. His passion extends to the creation of theranostic platforms for early disease diagnosis and personalized medicine.

Awards

Throughout his career, Dr. Thakur has received numerous accolades for his contributions to pharmaceutical sciences. Notable among them are the John B. Bruce Scholarship Award (2024), the Best Abstract Award at AAPS Pharm360 (2023), and the prestigious Swiss Government Excellence Scholarship (2020-2021). His earlier achievements include the DST-INSPIRE and CSIR Research Fellowships, which are awarded to the top 1% of students in India. These recognitions underscore his impact on the scientific community and his leadership in advancing pharmaceutical research.

Publications

Dr. Thakur has authored 29 peer-reviewed papers, with some of his recent work focused on innovative drug delivery systems. Key publications include:

Thakur, N.S., et al., “Crosslinked Hybrid Nanoparticle Embedded in Thermogel For Sustained Co-Delivery to Inner Ear,” Journal of Nanobiotechnology, 2024.

Thakur, N.S., et al., “Progress and Promise of Photoresponsive Nanocarriers for Precision Drug Delivery in Cancer,” Journal of Photochemistry & Photobiology C: Photochemistry Reviews, 2024.

Thakur, N.S., et al., “Dual Stimuli-Responsive and Sustained Drug Delivery Nanosensogel for Prevention of Cisplatin-Induced Ototoxicity,” Journal of Controlled Release, 2024.

Paul, S., et al., “Co-Administration of Chemo-Phototherapeutic Loaded Lignin Nanoarchitecture for Skin Cancer and Bacterial Infections,” ACS Applied Nano Materials, 2024.

Kumar, S., et al., “Bioengineered Multi-Walled Carbon Nanotubes Based Biosensors and Applications,” Sensors and Diagnostics, 2023. These works, which cover nanomedicine, drug delivery, and nanomaterial innovation, have significantly contributed to the field of pharmaceutical sciences and have been widely cited.

Conclusion

Dr. Neeraj S. Thakur’s multifaceted career highlights his dedication to advancing pharmaceutical research through innovation in nanotechnology and drug delivery systems. His profound knowledge in both academic and industrial settings, along with his leadership in driving collaborative research projects, continues to position him as a key figure in his field. With a focus on precision medicine, AI-based design, and the development of targeted therapies, Dr. Thakur is making remarkable strides toward improving patient outcomes and advancing the future of drug delivery and diagnostics.